Thor Medical ASA announced that When Mr. Jasper Kurth (39) assumes the position as Chief Executive Officer, Dr. Alf Bjørseth (82), will continue to support the company's client acquisition and technical development of a production facility for thorium-based alpha emitters at Herøya, Norway as Senior Vice President & Strategic Advisor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 NOK | +1.89% | +1.31% | -16.28% |
Feb. 28 | Transcript : Thor Medical ASA, H2 2023 Earnings Call, Feb 28, 2024 | |
Feb. 14 | Thor Medical ASA Announces CEO Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-16.28% | 22.97M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NANOV Stock
- News Thor Medical
- Thor Medical ASA Appoints Alf Bjørseth as Senior Vice President & Strategic Advisor